327 related articles for article (PubMed ID: 6352025)
21. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Weiss HJ
Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351
[TBL] [Abstract][Full Text] [Related]
22. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
23. Platelets and antiplatelet therapy in ischemic heart disease.
Frishman WH; Miller KP
Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
[No Abstract] [Full Text] [Related]
24. Trials of antiplatelet drugs: some methodological considerations.
Armitage P
Rev Epidemiol Sante Publique; 1979 Sep; 27(2):87-90. PubMed ID: 538303
[No Abstract] [Full Text] [Related]
25. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
Furberg CD; May GS
Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
[TBL] [Abstract][Full Text] [Related]
26. Platelets and coronary heart disease: therapy update.
Mehta JL
Geriatrics; 1982 May; 37(5):129-34, 139. PubMed ID: 7040169
[No Abstract] [Full Text] [Related]
27. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
28. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
Van Aken WG
Adv Cardiol; 1982; 31():98-101. PubMed ID: 6758512
[No Abstract] [Full Text] [Related]
29. Antiplatelet therapy.
Turpie AG
Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
[No Abstract] [Full Text] [Related]
30. The current status of platelet suppressive drugs in the treatment of thrombosis.
Hirsh J; Gent M; Genton E
Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
[No Abstract] [Full Text] [Related]
31. Drugs in the treatment of thrombo-embolic disease--part I.
Bouchier-Hayes D
Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
[No Abstract] [Full Text] [Related]
32. [Platelets and coronary artery disease (CAD) (author's transl)].
Reimers HJ; Misera R; Schneider W; Loogen F
Z Kardiol; 1980 Dec; 69(12):799-814. PubMed ID: 7025482
[TBL] [Abstract][Full Text] [Related]
33. Platelets and prostaglandins in sudden death: therapeutic implications.
Gelman JS; Mehta J
Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
[No Abstract] [Full Text] [Related]
34. Antiplatelet drugs in thromboembolism.
Hirsh J
Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
[TBL] [Abstract][Full Text] [Related]
35. Status of antiplatelet drugs in coronary heart disease.
Mehta J; Mehta P
JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
[No Abstract] [Full Text] [Related]
36. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
McNicol GP
Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
[No Abstract] [Full Text] [Related]
37. [Blood platelets and myocardial infarction].
Musiał J; Dworski R; Szczeklik A
Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
[No Abstract] [Full Text] [Related]
38. Antithrombotic agents in coronary artery disease.
Resnekov L; Chediak J; Hirsh J; Lewis D
Chest; 1986 Feb; 89(2 Suppl):54S-67S. PubMed ID: 3510831
[No Abstract] [Full Text] [Related]
39. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Hirsh J
Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
[TBL] [Abstract][Full Text] [Related]
40. Does aspirin prevent stroke?
Mitchell JR
Practitioner; 1979 Nov; 223(1337):668-72. PubMed ID: 394138
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
